Russia invaded Ukraine on 24 of February 2022. Stand with Ukraine and support us in a fight for freedom and democracy in Europe.  Stand with Ukraine!  Join us
search
The #1 Medical Tourism Platform since 2014

Best Immunohistochemistry diagnosticians in Turkey: TOP 26 doctors

author
Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Mustafa Solak
Clinical oncologist
18 years of experience
4.5
109 reviews
Turkey, Istanbul
Hisar Intercontinental Hospital

Mustafa Solak

Clinical oncologist
18 years of experience

Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

Read more
4.5
109 reviews
Doctor's visit price on request
Tummy tuck $5676
Heart Valve Replacement $12000
Myomectomy (removal of uterine fibroids) $3750 - $4500
More treatments
Suleyman Hilmi Aksoy
Radiologist
22 years of experience
4.5
109 reviews
Turkey, Istanbul
Hisar Intercontinental Hospital

Suleyman Hilmi Aksoy

Radiologist
22 years of experience
Dr. Hilmi Aksoy was born in 1974 and graduated from Istanbul University's Çapa School of Medicine in 1998. He completed his residency in Radiodiagnostics and Interventional Radiology at Cerrahpaşa School of Medicine in 2002. He has participated in 13 local and international congresses with oral and written presentations. His fields of medical interest include Diagnostic Radiology and Teleradiology and Interventional Radiology. He has worked at Hisar Intercontinental Hospital, Merzifon Air Hospital, Istanbul Emar Center, and Haseki Training and Research Hospital.Read more
4.5
109 reviews
Doctor's visit price on request
Tummy tuck $5676
Heart Valve Replacement $12000
Myomectomy (removal of uterine fibroids) $3750 - $4500
More treatments
Serdar Bedii Omay
Hematologist
34 years of experience
4.2
31 reviews
Turkey, Istanbul
Emsey Hospital

Serdar Bedii Omay

Hematologist
34 years of experience

Prof. Dr. Serdar Bedii Omay graduated from Hacettepe Medical School in 1985 and later specialized in Internal Medicine and Hematology. He has published 65 scientific articles, 112 meeting papers, and 34 conference presentations in the field of Hematology and Bone Marrow Transplantation. He has also worked as a Hematology Specialist and Molecular Hematology Doctor at Japan Mie Medical Faculty in 1995.

Read more
4.2
31 reviews
Doctor's visit price on request
Heart Valve Replacement $14000 - $23000
Chemotherapy $1500 - $5000
Mastectomy $6905
More treatments
Birol Baytan
Pediatric hematologist
32 years of experience
4.2
31 reviews
Turkey, Istanbul
Emsey Hospital

Birol Baytan

Pediatric hematologist
32 years of experience

Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.

Read more
4.2
31 reviews
Doctor's visit price on request
Heart Valve Replacement $14000 - $23000
Chemotherapy $1500 - $5000
Mastectomy $6905
More treatments
Elnur Sahibov
Radiation oncologist
8 years of experience
4.2
31 reviews
Turkey, Istanbul
Emsey Hospital

Elnur Sahibov

Radiation oncologist
8 years of experience

Licensed Radiation Oncologist with 8 years of medical training, including undergraduate studies at Marmara University Faculty of Medicine (2004-2011) and Radiation Oncology specialization training at Marmara University Faculty of Medicine (2012-2016). Previous education from Sixteen Numbered Shirvan School (Azerbaijan) High School (1998-2004).

Read more
4.2
31 reviews
Doctor's visit price on request
Heart Valve Replacement $14000 - $23000
Chemotherapy $1500 - $5000
Mastectomy $6905
More treatments
Songul Serefhanoglu
Hematologist
15 years of experience
4.2
5 reviews
Turkey, Istanbul
ISU Gaziosmanpasa

Songul Serefhanoglu

Hematologist
15 years of experience

Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.

Read more

Find out about the best doctors here

20 top ranked Immunohistochemistry doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Immunohistochemistry doctors on Bookimed.com:

How to choose the best Immunohistochemistry doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Immunohistochemistry doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Immunohistochemistry varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Immunohistochemistry if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Mehmet Cemil Uygur
Urological surgeon
37 years of experience
4.3
86 reviews
Turkey, Istanbul
Medicana Atasehir Hospital

Mehmet Cemil Uygur

Urological surgeon
37 years of experience

accreditations:

European Association of Urology
American Urological Association
Society of Urologic Oncology

orchiopexy in cryptorchidism: a single centre experience with long-term follow-up. PEDIATRIC SURGERY INTERNATIONAL, 18 : 140-141, 2002

 

Uygur MC, Tan MO, Ünal D, Erol D: The outcome of one-stage repair of proximal hypospadias with wide ventral preputial island flap. PEDIATRIC SURGERY INTERNATIONAL, 18: 139-140, 2002

Dr. Uygur is an international urologist with a Medical Graduate and M.D. Degree from Hacettepe University Medical School, a research fellowship from the Transplantation Laboratory of Helsinki University, and residency in Urology from Hacettepe University Medical School. He has over 300 international and national publications and presentations, with 781 scientific citations to 41 articles. He is a full member of the European Association of Urology, a corresponding member of the American Urological Association, a member of the Society of Urologic Oncology, and a board member of the Turkish Society of Urologic Oncology. He has completed robotic urologic surgery courses at Vanderbilt University Hospital, the Cleveland Clinic, and the USC Norris Comprehensive Cancer Center. He is the Professor of Urology and Chair at the Near East University Medical School, the Chief of Urology at the Anadolu Medical Center in Affiliation with Johns Hopkins Medicine, and the Director of Urooncology and Urologic Robotic Surgery Programmes at the Anadolu Medical Center. He is also a scientific secretary of biannual Ankara Urooncology Courses, and has organized many national or regional Urology and Urooncology meetings.

Read more
4.3
86 reviews
Doctor's visit price on request
Thyroid resection $5000 - $6000
Tummy tuck $3000
Blepharoplasty (Eyelid correction) $2000 - $3000
More treatments
Hilmi Apak
Pediatric hematologist
24 years of experience

Hilmi Apak

Pediatric hematologist
24 years of experience
Turkey, Istanbul
Biruni University Hospital
Murat Sarikaya
Gastroenterologist
20 years of experience
4.0
1 review
Turkey, Istanbul
Medipol Bahçelievler Hospital

Murat Sarikaya

Gastroenterologist
20 years of experience
Experience:2022 - Medipol Bahçelievler2021 - 2022MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL2018 - 2020İSTİNYE UNIVERSITY FACULTY OF MEDICINE2014 - 2020TOKAT STATE HOSPITAL2010 - 2010BINGOL STATE HOSPITAL Education:2021MEDIPOL UNIVERSITY, GASTROTEROLOGY2018İSTINYE UNIVERSITY, INTERNAL DISEASES USA2014ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY2010FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT2004FIRAT UNIVERSITY, FACULTY OF MEDICINE A. International Peer-Reviewed Journal Articles:Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Babalı Ayşegül, Çakal BaşakJournal: Acta Gastro-Enterologica BelgicaYear: 2012Volume/Issue: (Kontrol No: 1206043)Title: Acute gastric obstruction resulting from gallstone-induced bezoar.Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Akbal ErdemJournal: The American SurgeonYear: 2012Volume/Issue: 78(12)Page: 529(Kontrol No: 1129707)Title: Garlic-induced esophagitis.Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül BilalJournal: Acta Gastro-Enterologica BelgicaYear: 2013Volume/Issue: 76(2)Page: 262(Kontrol No: 1131422)Title: Association between Helicobacter pylori and liver-to-spleen ratio.Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül BilalJournal: European Journal of Gastroenterology & HepatologyYear: 2013Volume/Issue: 25(1)Pages: 107-110Citations: 7DOI: 10.1097/MEG.0b013e3283590c10(Kontrol No: 1131424)Title: Crohn's disease masked by median arcuate ligament syndrome.Authors: Bıyıkoğlu İbrahim, Sarıkaya Murat, Uysal Ramadan Selma, Ergül Bilal, Doğan ZeynalJournal: Chinese Medical JournalYear: 2013Volume/Issue: 126 (14)Page: 2798Citations: 1(Kontrol No: 1131477)Title: Telaprevir and anemia: What we learned from the first three patients.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik LeventJournal: Scandinavian Journal of Infectious DiseasesYear: 2013Volume/Issue: 45(7)Page: 575-575Citations: 2DOI: 10.3109/00365548.2012.759271(Kontrol No: 1129738)Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.Authors: Sarıkaya Murat, Filik Levent, Ergul Bilal, Doğan ZeynalJournal: Gastroenterology NursingYear: 2013Volume/Issue: 36 (2)Pages: 145-148DOI: 10.1097/SGA.0b013e31828d3753(Kontrol No: 1129715)Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?Authors: Ergül Bilal, Sarıkaya Murat, Doğan Zeynal, Filik Levent, Bıyıkoğlu İbrahimJournal: Digestive EndoscopyYear: 2013Volume/Issue: 25(1)Pages: 90-91Citations: 2DOI: 10.1111/j.1443-1661.2012.01383.x(Kontrol No: 1129879)Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.Authors: Sarıkaya Murat, Filik Levent, Doğan Zeynal, Ergül BilalJournal: Gastroenterology NursingYear: 2013Volume/Issue: 36(2)Pages: 141-144DOI: 10.1097/SGA.0b013e31828d33db(Kontrol No: 1129712)Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."Authors: Bilal Ergül, Murat Sarıkaya, Zeynal Doğan, Sevda İdil, Tarkan Karakan, Abdullah Çetin KöseoğluJournal: Case Reports in Gastrointestinal MedicineYear: 2013Volume/Issue: 2013Article ID: 725434DOI: 10.1155/2013/725434(Kontrol No: 1131423)Title: Severe acute pancreatitis due to hypertriglyceridemia.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Bıyıkoğlu İbrahimJournal: Case Reports in Gastrointestinal MedicineYear: 2013Volume/Issue: 2013Article ID: 945902DOI: 10.1155/2013/945902(Kontrol No: 1131425)Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Sevda İdilJournal: Case Reports in MedicineYear: 2013Volume/Issue: 2013Article ID: 652960DOI: 10.1155/2013/652960(Kontrol No: 1131426)Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik LeventJournal: Case Reports in Gastrointestinal MedicineYear: 2013Volume/Issue: 2013Article ID: 604820DOI: 10.1155/2013/604820(Kontrol No: 1131427)Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik LeventJournal: Turkish Journal of GastroenterologyYear: 2013Volume/Issue: 24(3)Pages: 276-280DOI: 10.4318/tjg.2013.0565(Kontrol No: 1129727)Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Tarkan KarakanJournal: Case Reports in Gastrointestinal MedicineYear: 2013Volume/Issue: 2013Article ID: 658370DOI: 10.1155/2013/658370(Kontrol No: 1131475)Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik LeventJournal: Case Reports in Gastrointestinal MedicineYear: 2013Volume/Issue: 2013Article ID: 925259DOI: 10.1155/2013/925259(Kontrol No: 1131476)B. Contributions to Scientific Conferences:Title: Suicidal poisonings in Turkey: demographic and clinical aspects.Authors: Sarikaya M., Gunes A., Goksu E., Erdogan G., Ozen C., Kaya A.Conference: 30th European Congress of Clinical Toxicology (EAPCCT)Year: 2000Abstract ID: P44(Kontrol No: 1131478)Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül BilalConference: World Congress of GastroenterologyYear: 2013Abstract ID: P1367(Kontrol No: 1131479)Read more
4.0
1 review
Doctor's visit price on request
Blepharoplasty (Eyelid correction) $4000
Otoplasty (ear surgery) $3000
Breast lift $5000
More treatments
Nese Guney
Clinical oncologist
26 years of experience

Nese Guney

Clinical oncologist
26 years of experience
Turkey, Istanbul
Biruni University Hospital
Ali Eser
Hematologist
24 years of experience
4.5
109 reviews
Turkey, Istanbul
Hisar Intercontinental Hospital

Ali Eser

Hematologist
24 years of experience
Assoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.Read more
4.5
109 reviews
Doctor's visit price on request
Tummy tuck $5676
Heart Valve Replacement $12000
Myomectomy (removal of uterine fibroids) $3750 - $4500
More treatments
Savash Kansoy
Pediatric hematologist/oncologist
46 years of experience
4.6
453 reviews
Turkey, Istanbul
Anadolu Medical Center

Savash Kansoy

Pediatric hematologist/oncologist
46 years of experience
EducationEge Faculty of Medicine 1978Specialization in Pediatrics 1982Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)Deputy Chief of Clinic 1988 Tepecik EAHClinical Chief 1993 Tepecik EAHAssociate Professorship 1995Professorship  2002Ege U. Faculty of Medicine, faculty member 1998 – 2022EU Faculty of Medicine Department of Pediatrics 2009-2018Member of Tepecik Education Planning and Coordination Board (1993-1998)SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021Institutional MembershipsTurkish Medical Association İzmir and Kocaeli BranchTurkish National Pediatric Association - İzmirEuropean Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)Turkish Society of Hematology - Board Member for two terms (2001/2005)Turkish Pediatric Oncology AssociationBone Marrow Transplantation Foundation (KITVAK) Member of the Board of TrusteesUnits he is the founder of                        1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  Transplantation units that he contributed to the establishment of                        1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)AwardsThrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research awardThe role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmirNational pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, AntalyaPublicationsKansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmirKansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, IzmirKansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020National pediatric stem cell transplant activity, 2020Childhood stem cell transplantation indications, Turkey Clinics - International book 2020In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.Read more
4.6
453 reviews
Doctor's visit price on request
Laparoscopic nephrectomy $13000 - $16000
Heart Valve Replacement $28000
Thyroid resection $5000 - $6500
More treatments
Dilvin Chelik Atesh
Pediatric hematologist
24 years of experience
5.0
13 reviews
Turkey, Istanbul
Group Florence Nightingale Hospitals

Dilvin Chelik Atesh

Pediatric hematologist
24 years of experience
Undergraduate and Doctoral Education:* 1992-1999 Ondokuz Mayıs University Faculty of Medicine* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,Pediatrics Residency* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, PediatricHematology and Oncology Subspecialization*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)Read more
Muhammed Gomec
Colorectal surgeon
15 years of experience
5.0
1 review

Muhammed Gomec

Colorectal surgeon
15 years of experience
Turkey, Sivas
Medicana Sivas Hospital
Alandag Celal
Clinical oncologist
15 years of experience
5.0
1 review

Alandag Celal

Clinical oncologist
15 years of experience
Turkey, Sivas
Medicana Sivas Hospital
Nail Paksoy
Oncologist/mammologist
13 years of experience
4.0
1 review
Turkey, Istanbul
Medipol Bahçelievler Hospital

Nail Paksoy

Oncologist/mammologist
13 years of experience

accreditations:

ESMO Board Certification in Medical Oncology
PROFESSIONAL EXPERIENCE2011-2012Erzurum Koprukoyu State HospitalDepartment: General Medicine2012-2017Istanbul University Cerrahpaşa Medical FacultyDepartment: Internal Medicine06/2017-10/2017Istanbul Gaziosmanpasa Taksim Training and Research HospitalDepartment: Internal Medicine10/2017-11/2018Istanbul University Istanbul Medical FacultyDepartment: Allergy and Immunology Fellowship2018/2022Istanbul University Oncology InstituteDepartment: Medical Oncology Fellowship2022-2023Tekirdag City HospitalDepartment: Medical Oncology Specialist2023-presentIstanbul Medipol University Medipol Bahcelievler Private HospitalDepartment: Medical Oncology Assoc. Prof. EDUCATION2005-2011Medical EducationSivas Cumhuriyet University Medical Faculty, Sivas, Turkey2012-2017Internal MedicineIstanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey2017-2018Allergy-Immunology FellowshipIstanbul University Istanbul Medical FacultyDepartment of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey2018-2022Medical Oncology FellowshipIstanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey2022ESMO Board Certification in Medical Oncology10th September 2022 in Paris, France.2023Medical Oncology Assoc. Prof.Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey INTERNATIONAL CLINICAL TRIALS:1. Astefania - ROCHETitle: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative TherapyRole: Subinvestigator2. PFİZERTitle: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLCRole: Subinvestigator3. RECITE - AMGENTitle: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerRole: Subinvestigator4. NAVIGATE - BAYERTitle: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsRole: Subinvestigator5. RUBY - Tesaro (PRA)Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial CancerRole: Subinvestigator6. ENGOT-ov43/GOG-3036 - MSDTitle: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)Role: Subinvestigator7. ASTRA ZENECATitle: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.Role: Subinvestigator8. ROSY-O - ASTRA ZENECATitle: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibRole: Subinvestigator INTERNATIONAL PUBLICATIONSI. Published journal articles indexed by SCI, SSCI, and AHCIWeekly Paclitaxel in Classic Kaposi SarcomaAuthors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.Journal: Medicine, 102(5)Carboplatin Desensitization in Ovarian CarcinomaAuthors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.Journal: Medicine, 101(45), e31726High-Dose Chemotherapy for Ewing’s SarcomaAuthors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.Journal: Medicine, 101(49), e32213Multidrug Refractory TFE3(+) Renal Cell CarcinomaAuthors: Paksoy, Nail, et al.Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221Crizotinib Efficacy in NSCLC with MET AlterationsAuthors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.Journal: Medicine, 101(50), e32368Clinicopathological Features in ALK Mutant NSCLCAuthors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.Journal: Medicine, 101(34)PSMA-Based Tumor Burden in Prostate CancerAuthors: HAS SIMSEK, Duygu, et al.Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690Atezolizumab in Metastatic Urothelial CarcinomaAuthors: TURAL, Deniz, et al.Journal: European Urology Focus, 2021, 7.5: 1061-1066Pulmonary Sarcomatoid CarcinomaAuthors: FERHATOGLU, Ferhat, et al.Journal: Oncology Research and Treatment, 2021, 44.11: 590-601Prognostic Factors in Atezolizumab-Treated Urothelial CarcinomaAuthors: TURAL, Deniz, et al.Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513Atezolizumab with Chemotherapy in Small Cell Lung CancerAuthors: GÜRBÜZ, Mustafa, et al.Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic CancerAuthors: AY, Seval, et al.Journal: Journal of Chemotherapy, 2022, 1-7Trastuzumab Emtansine in Older HER2-Positive Breast Cancer PatientsAuthors: CIL, Ibrahim, et al.Journal: Tumori Journal, 2022, 108.1: 19-25Real-Life Efficacy of Osimertinib in Advanced NSCLCAuthors: HIZAL, Mutlu, et al.Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508ALK-Positive Cells Percentage and Alectinib EfficacyAuthors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148Real-World Data on Alectinib in ALK-Positive NSCLCAuthors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.Journal: Future Oncology, 18(23), 2573-2582Prognostic Factors in Metastatic RCC with T790M MutationAuthors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsFLOT Regimen in Metastatic Gastric CancerAuthors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.Journal: Journal of Cancer Research and TherapeuticsDesensitization Protocol in Lenalidomide Hypersensitivity ReactionsAuthors: DEMIR, Semra, et al.Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397Factors Associated with Diagnostic Skin Test Positivity in PPI HypersensitivityAuthors: ÖZDEMIR, Seçil Kepil, et al.Journal: Allergy, 2019, 74.6: 1187-1190Efficacy of Capecitabine and Temozolomide in Neuroendocrine TumorsAuthors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.Journal: The Oncologist, oyad257Subsequent Treatments in Hormone-Positive Breast Cancer ProgressionAuthors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.Journal: BMC cancer, 23(1), 192Termination of Trastuzumab in HER2-Positive Metastatic Breast CancerAuthors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.Journal: Scientific Reports, 13(1), 8779Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast CancerAuthors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.Journal: Journal of Cancer Research and Clinical Oncology, 1-9Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast CancerAuthors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.Journal: European Journal of Breast Health, 19(2), 128Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast CancerAuthors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.Journal: Future Oncology, 19(10), 727-736Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma PatientsAuthors: Dogan, I., Paksoy, N., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsSingle-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma PatientsAuthors: Dogan, I., Paksoy, N., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsOutcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain MetastasesAuthors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsFLOT Regimen in First-Line Treatment of Metastatic Gastric CancerAuthors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.Journal: Journal of Cancer Research and TherapeuticsPrognostic Factors of Perioperative FLOT Regimen in Operable Gastric CancerAuthors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.Journal: [Not specified]Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi SarcomaAuthors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.Journal: Medicine, 102(39), e35383Comparison of Second-Line Treatments in Metastatic Renal Cell CarcinomaAuthors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.Journal: Medicine, 102(41), e35245Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGYPredictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of PulmonologyLaterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye Thesis:Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combinationAuthors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group studyAuthors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancerAuthors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)Efficacy of temozolomide in pretreated patients with metastatic sarcomaAuthors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumorsAuthors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcomaAuthors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastasesAuthors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinomaAuthors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk studyAuthors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiencesAuthors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)  Read more
4.0
1 review
Doctor's visit price on request
Blepharoplasty (Eyelid correction) $4000
Otoplasty (ear surgery) $3000
Breast lift $5000
More treatments
Zulfu Sertkaya
Clinical oncologist
16 years of experience

Zulfu Sertkaya

Clinical oncologist
16 years of experience
Turkey, Istanbul
Andro Expertise Clinic
Hamza Ugur Bozbey
Clinical oncologist
10 years of experience

Hamza Ugur Bozbey

Clinical oncologist
10 years of experience
Turkey, Istanbul
Uniqacare Clinic
Osman Ilhan
Hematologist
46 years of experience
2.0
1 review
Turkey, Ankara
Private Koru Ankara Hospital

Osman Ilhan

Hematologist
46 years of experience

accreditations:

European Hematology Association
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023. His medical interests include: Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic) Acute Leukemia Chronic Leukemia Treatments Hodgkin Lymphoma Non-Hodgkin Lymphoma Treatments Multiple Myeloma Treatments, MDS Aplastic Anemia ITP TTP Treatments Hypercoagulability Hereditary Thrombophilia Treatments Therapeutic Apheresis Photopheresis Geriatric Hematology Diseases. Read more
Kayihan Engin
Radiation oncologist
39 years of experience
5.0
1 review
Turkey, Bursa
Medicana Bursa Hospital

Kayihan Engin

Radiation oncologist
39 years of experience

accreditations:

Certificate of Specialty
Dr. has a medical diploma from Uludağ University Medical College, Bursa, Turkey (1983), post-doctoral fellowship in Thermoradiotherapy from Thomas Jefferson University, Philadelphia, PA (1990-1994), and residency in Radiation Oncology from Center of Oncology & Nuclear Medicine, Istanbul, Turkey (1990). He has also held positions as professor, chairman, and faculty accreditation coordinator at Uludağ University Medical College (1991-2005), professor and director at Anadolu Medical Center (2004-2017), and director at Ceylan International Hospital and Medicana Bursa Hospital (2017-present).Read more

Related Articles